Medscape April 26, 2024
Matías A. Loewy

ASUNCIÓN, PARAGUAY — Sarcopenic obesity, which is characterized by excess adiposity and muscle loss, is an “underestimated and underdiagnosed” condition, said the panelists at a session of the XV Latin American Obesity Congress (FLASO 2024) and II Paraguayan Congress of Obesity. The condition often affects older adults but can also occur at any age as a result of unhealthy habits or intensive or repeated weight loss efforts.

“The drugs currently used for managing obesity promote significant weight loss, but by losing fat, muscle is also lost,” said Fabiola Romero Gómez, MD, a professor of medicine at the National University of Asunción and president of the Paraguayan Society of Endocrinology and Metabolism. “We must handle [these drugs] with extreme care. When...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Patient / Consumer, Provider, Trends
GLP1 Drugs Not Tied to Pregnancy Loss, Birth Defects
Mental health treatment plan goals: Setting providers and patients up for success
High board exam scores linked to reduced patient deaths
62 percent of young adults wouldn't live in state with abortion ban: Survey
STAT+: Young boy dies in trial for Pfizer Duchenne gene therapy

Share This Article